2.72
4.90%
-0.14
After Hours:
2.73
0.010
+0.37%
Akoya Biosciences Inc stock is traded at $2.72, with a volume of 102.23K.
It is down -4.90% in the last 24 hours and up +6.67% over the past month.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
See More
Previous Close:
$2.86
Open:
$2.94
24h Volume:
102.23K
Relative Volume:
0.60
Market Cap:
$133.15M
Revenue:
$96.63M
Net Income/Loss:
$-63.32M
P/E Ratio:
-1.3807
EPS:
-1.97
Net Cash Flow:
$-54.55M
1W Performance:
-1.81%
1M Performance:
+6.67%
6M Performance:
-42.00%
1Y Performance:
-41.51%
Akoya Biosciences Inc Stock (AKYA) Company Profile
Name
Akoya Biosciences Inc
Sector
Industry
Phone
855.896.8401
Address
100 CAMPUS DRIVE, MARLBOROUGH
Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-05-23 | Resumed | JP Morgan | Overweight |
Feb-02-23 | Initiated | UBS | Buy |
Nov-03-22 | Initiated | CapitalOne | Overweight |
Oct-06-22 | Initiated | Stephens | Overweight |
Jun-22-22 | Initiated | BTIG Research | Buy |
Jan-06-22 | Resumed | Piper Sandler | Overweight |
May-11-21 | Initiated | Canaccord Genuity | Buy |
May-11-21 | Initiated | JP Morgan | Overweight |
May-11-21 | Initiated | Morgan Stanley | Overweight |
May-11-21 | Initiated | Piper Sandler | Overweight |
View All
Akoya Biosciences Inc Stock (AKYA) Latest News
Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Declines By 6.4% - MarketBeat
Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth By Investing.com - Investing.com South Africa
Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth - Investing.com
Brokerages Set Akoya Biosciences, Inc. (NASDAQ:AKYA) Target Price at $6.56 - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Piper Sandler Maintains Akoya Biosciences (AKYA) Overweight Recommendation - MSN
Akoya Biosciences, Inc.'s (NASDAQ:AKYA) biggest owners are private equity firms who got richer after stock soared 18% last week - Simply Wall St
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 6.3% in August - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Europe, CIS & Africa Spatial Transcriptomics (Instruments, Consumables) Market Size, Share & Trends Analysis Report 2024-2030 - GlobeNewswire Inc.
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Growth in Short Interest - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Increase in Short Interest - MarketBeat
Vanguard Group Inc. Has $6.82 Million Stock Position in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $4.00 at Piper Sandler - Defense World
Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $4.00 at Piper Sandler - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target - Simply Wall St
FY2024 EPS Estimates for Akoya Biosciences, Inc. Raised by Capital One Financial (NASDAQ:AKYA) - MarketBeat
Capital One Financial Research Analysts Boost Earnings Estimates for Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint - Yahoo Finance
Closing Figures: Akoya Biosciences Inc (AKYA)’s Negative Finish at 2.01, Down -6.51 - The Dwinnex
Insiders Give Up US$52k As Akoya Biosciences Stock Drops To US$2.01 - Simply Wall St
JP Morgan Downgrades Akoya Biosciences (AKYA) - MSN
Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $7.00 at Craig Hallum - Defense World
Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $7.00 by Analysts at Craig Hallum - MarketBeat
Akoya Biosciences (NASDAQ:AKYA) Releases Quarterly Earnings Results, Hits Expectations - MarketBeat
Morgan Stanley cuts Akoya Biosciences rating on capital spend concerns - Investing.com
Akoya Biosciences (NASDAQ:AKYA) Cut to “Equal Weight” at Morgan Stanley - Defense World
A Closer Look at 4 Analyst Recommendations For Akoya Biosciences - Benzinga
BTIG cuts Akoya Biosciences stock rating amid revenue, staff concerns By Investing.com - Investing.com Australia
Akoya Biosciences (NASDAQ:AKYA) Issues Quarterly Earnings Results - Defense World
JPMorgan Chase & Co. Lowers Akoya Biosciences (NASDAQ:AKYA) to Neutral - American Banking and Market News
Akoya Biosciences (NASDAQ:AKYA) Cut to "Equal Weight" at Morgan Stanley - MarketBeat
JPMorgan Chase & Co. Lowers Akoya Biosciences (NASDAQ:AKYA) to Neutral - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Akoya Biosciences sees revenue jump, aims for break-even - Investing.com Canada
BTIG cuts Akoya Biosciences stock rating amid revenue, staff concerns - Investing.com
Akoya: Q2 Earnings Snapshot - San Antonio Express-News
Akoya stock downgraded by JPMorgan after persistent macroeconomic pressures - Investing.com
Akoya Biosciences Reports Second Quarter 2024 Financial Results - ForexTV.com
Akoya: Q2 Earnings Snapshot - The Washington Post
Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript - Seeking Alpha
Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Akoya Biosciences Reports Second Quarter 2024 Financial Results - StockTitan
Akoya Biosciences Reports Second Quarter 2024 Financial Results - GlobeNewswire
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Silvercrest Asset Management Group LLC Makes New Investment in Akoya Biosciences, Inc. (NASDAQ:AKYA) - MarketBeat
Akoya Biosciences (AKYA) to Release Earnings on Monday - MarketBeat
Akoya Biosciences (AKYA) to Release Quarterly Earnings on Monday - Defense World
Akoya Biosciences stock maintains $6 price target with Buy rating at BTIG - Investing.com
Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Expands By 15.6% - American Banking and Market News
Akoya Biosciences Inc Stock (AKYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):